Selegiline improves excessive daytime sleepiness in Parkinson's disease: an open-label observational study

Chin Med J (Engl). 2022 Jul 20;135(14):1762-1764. doi: 10.1097/CM9.0000000000002308.
No abstract available

Publication types

  • Observational Study

MeSH terms

  • Disorders of Excessive Somnolence*
  • Humans
  • Parkinson Disease* / drug therapy
  • Selegiline / therapeutic use
  • Severity of Illness Index

Substances

  • Selegiline